Showing 41-50 of 3366 results for "".
Physician Spotlight: Christopher Bunick, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-christopher-bunick-md-phd/23911/Physician Spotlight: Steven R. Feldman, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-steven-r-feldman-md-phd/20779/Amid roadblocks, opportunities exist to improve adherence among dermatology patientsPhysician Spotlight: Steven R. Feldman, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-steven-r-feldman-md-phd/20541/The new thinking on improving adherence in dermatology.Physician Spotlight: George Han, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-george-han-md-phd/23666/Journal Club: Atopic Dermatitis Control Tool
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-atopic-dermatitis-control-tool/26734/Peter Lio, MD, talks with Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist practicing in Boise, Idaho, about the Atopic Dermatitis Control Tool (ADCT). Highlighted in a recent study published in the British Journal of Dermatology, the ADCT has been said to provide patienJournal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-oral-jak-inhibitors-moderate-severe-ad/24539/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a dermatologist at Seattle Children's Hospital, about nuanced differences in guideline-recommended use of oral JAK inhibitors in pediatric patients with moderate-to-severe atopic dermatitis (AD) provided in the Annals of Allergy, Asthma, and ImmunolPhysician Spotlight: Jody Comstock, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-jody-comstock-md-phd/20525/Exploring the role of physician assistants in cosmetic dermatology.Journal Club: Tapinarof Cream in Pediatric Patients
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-tapinarof-cream-in-pediatric-patients/32399/Practical Dermatology Editorial Board member Peter Lio, MD, speaks with Mona Shahriari, MD, about the Journal of Dermatology article "A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis," and the general importance ofIntegrative Approaches to Skincare: What is the Evidence?
https://practicaldermatology.com/conferences/aad-2021/integrative-approaches-to-skincare-what-is-the-evidence/19922/Alternative approaches to care may offer benefits for patients—especially when combined with conventional medical approaches. Peter Lio, MD discusses the reasons patients may turn to alternative approaches for acne, eczema, hair loss, and more. He touches on potential biases in looking at the data aApproaches to Treating Mild, Moderate, and Severe Cases of Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37161/Practical Dermatology Editorial Board member Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine, discusses how atopic dermatitis treatment approaches should differ based on whether the condition is mild, moderate, or sev